CTOR Q1 2026 Earnings Significant EPS Miss Amid PreRevenue Stage USPH Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment Despite Operational Consistency EXR Q1 2026 Earnings Slight EPS Beat Amid Market Headwinds SBEV Q2 2025 Earnings WiderThanExpected Loss Drives Stock Down Over 4 DECK Q1 2026 Earnings EPS Surpasses Estimates by 1337 BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility